Stock Analiz

Orchestra BioMed Holdings, Inc. (OBIO) stock forecast and price target

Price $7.25 · data as of November 13, 2026

12-month price target

Average target$12.83
Upside / downside+77.0%
Analysts6
ConsensusStrong buy
Low $10.00Average $12.83High $20.00

Gold marker: average target · white marker: today’s price ($7.25)

Analyst ratings

Strong buy 1Buy 5Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-1.33−20.1%$393170
Next fiscal year
ends December 31, 2027
$-1.27+4.8%$600140
Next quarter
ends December 31, 2026
$-0.33−226.9%$96670
Quarter after
ends December 31, 2026
$-0.31−219.2%$102200

Consensus of the analysts covering Orchestra BioMed, updated daily. In the last 30 days 2 estimates were raised and 1 lowered.

Frequently asked questions

What is the Orchestra BioMed stock price target?

The average 12-month target from 6 analysts is $12.83, 77.0% above the current price of $7.25 Targets range from $10.00 to $20.00.

Is Orchestra BioMed a buy according to analysts?

The consensus rating is “Strong buy” (1 strong buy, 5 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Orchestra BioMed expected to earn?

Analysts expect EPS of $-1.33 for the fiscal year ending December 31, 2026 and $-1.27 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.